Acquisition leverage GlobalCare has joined Covance, expanding global reach for patient-centric decentralized clinical trials. This presents a sales opportunity to cross-sell Covance’s DCT capabilities to existing Covance clients and to position integrated solutions in markets where GlobalCare’s footprint strengthens coverage.

Mid-size focus With 51-200 employees and revenue in the 10M–25M range, GlobalCare represents a mid-market CRO profile. Target growth initiatives, scale-up program services, and end-to-end trial management offerings tailored to mid-sized sponsors seeking global DCT capabilities.

DCT expertise GlobalCare’s patient-centric decentralized trials specialty aligns with sponsor demand for faster enrollment and remote monitoring. Propose expanded DCT service bundles, analytics-enabled site optimization, and technology-enabled patient engagement to capture growing market demand.

Technology stack The tech stack includes NoSQL, NIST frameworks, Flutter, CouchDB, and web/mobile technologies, suggesting capability in scalable, secure data platforms. Sales can emphasize robust cybersecurity, compliant data governance, and modern, mobile-ready trial tooling as competitive differentiators.

Growth signals Historical awards and partnerships with industry players (e.g., acquisitions and collaborations) indicate a growth-oriented trajectory. Position value propositions around accelerated time-to-market, expanded global access, and enhanced trial efficiency to capture potential client interest in transformative CRO partnerships.